| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 37 | Goldentree Asset Management Lp10% Owner | NONEKeenova Therapeutics plc Open-market purchase | BUY | $13.39M 150.0K sh | Nov 9, 2026 traded Nov 6, 2026 |
Congress trades and big insider sales, sent the day they're filed. Free.
Open in Telegram10% Owner · Keenova Therapeutics plc · Ordinary Shares
Open-market purchase
$13.0M reported value · 1.7% of prior position
Disclosed 2 business days after execution (deadline: 2)
First recorded trade by this actor in this security
No clustered activity in the dataset
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 37 | Goldentree Asset Management Lp10% Owner | NONEKeenova Therapeutics plc Open-market purchase | BUY | $13.39M 150.0K sh | Nov 9, 2026 traded Nov 6, 2026 |
Read directly from the primary public document; every field below is as reported by the filer.
Value = shares × reported price per share
= $13,005,153
Goldentree Asset Management Lp filed this Form 4 reporting a open-market purchase of NONE on Nov 5, 2026. It became public on Nov 9, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
No field has changed since this record was first ingested.
No material filings recorded for this issuer.
Price history for NONE is unavailable.
An error occurred in the Server Components render. The specific message is omitted in production builds to avoid leaking sensitive details. A digest property is included on this error instance which may provide additional details about the nature of the error.